Glossary
Drug Master File (DMF)
A submission to FDA of information on facilities, processes, drug substances, excipients or packaging materials that the holder lets other applicants rely on without disclosing it to them.
Source · 21 CFR 314.420 Drug master files
Japanese and UK inspection deficiencies on this topic
Deficiencies published by PMDA and MHRA whose wording uses this term, shown verbatim.
3. The organizational structure of the inspected site consisted that the manufacturing unit and quality unit are placed under the supervision of the authorized person for drug manufacture, and there are quality assurance department in charge of quality assurance operations and quality control …
PMDA · FY2025 · No.27 · Source fileIn the deviation case (control number X), batch X of intermediate X, in which the deviation occurred, failed to meet the specifications. These specifications were defined in the drug master file (hereinafter referred to as the "MF"), which also specified the procedures for handling intermediates …
PMDA · FY2023 · No.10 · Source fileFrom ● year to ● year this manfacturing site has been manufactured ● using an API intermediate procured from a manufacturing site that is not defined in the drug master file (hierinafter referred to MF, and the manufacturing site is referred to unapproved manufacturing site), and exported ● lots to …
PMDA · FY2024 · No.1 · Source file
Source
21 CFR 314.420 Drug master filesGRM Regulatory Glossary
256 GMP terms in one place
Each term is explained in plain language with its official source. Look it up here whenever you meet a term you don't know.
Browse the whole glossary